The University of Chicago Header Logo

Connection

Michael Davidson to Injections, Subcutaneous

Back to Details
This is a "connection" page, showing publications Michael Davidson has written about Injections, Subcutaneous.
Michael Davidson
Connection Strength
0.042
Injections, Subcutaneous
  1. IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet. 2021 05 29; 397(10289):2060-2069.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.